ebixa
h. lundbeck a/s - memantine hydrochloride - alzheimer disease - other anti-dementia drugs - treatment of patients with moderate to severe alzheimer's disease.
vyepti
h. lundbeck a/s - eptinezumab - migraine disorders - analgesics - vyepti is indicated for the prophylaxis of migraine in adults who have at least 4 migraine days per month.
serdolect 12 mg film-coated tablets 12 milligram film coated tablet
h. lundbeck a/s - sertindole - film coated tablet - 12 milligram
serdolect 16 mg film-coated tablets 16 milligram film coated tablet
h. lundbeck a/s - sertindole - film coated tablet - 16 milligram
serdolect 20 mg film-coated tablets 20 milligram film coated tablet
h. lundbeck a/s - sertindole - film coated tablet - 20 milligram
serdolect 4 mg film-coated tablets 4 milligram film coated tablet
h. lundbeck a/s - sertindole - film coated tablet - 4 milligram
bleomycin lundbeck
lundbeck limited - withdrawn form - 5 milligram
bleomycin lundbeck injection
lundbeck limited - bleomycin sulfate - pdr for soln inj/inf - 15 milligram
ccnu lundbeck capsules
lundbeck limited - lomustine - capsule - 10 milligram
serdolect 4 mg
lundbeck israel ltd. - sertindole - film coated tablets - sertindole 4 mg - sertindole - sertindole - for the treatment of schizophrenia. due to cardiovascular safety concerns serntidole should only be used for patients intolerant to at least one other anti-psychotic agent. sertindole should not be used in emergency situations for urgent relief of symptoms in acutely disturbed patients.